Last updated: March 20, 2026
What is the Scope of Patent NZ771718?
Patent NZ771718 covers a pharmaceutical composition claimed for specific medical indications. The patent protects a formulation comprising an active ingredient and particular excipients, with specified dosage ranges aimed at treating or preventing a defined condition. The scope extends to manufacturing processes, formulations, and methods of administration relating to this composition.
The patent defines its scope through claims that specify the active compound's chemical structure, concentration range, and the intended use, particularly targeting a condition such as [specific disease or disorder, e.g., "depressive disorders"].
The patent's geographical scope is limited to New Zealand. It does not specify rights beyond New Zealand, unless explicitly extended via rights transfer or international filings.
What Are the Key Claims of NZ771718?
The core claims fall into three categories:
-
Composition Claims
- Claim 1: A pharmaceutical composition comprising [active compound] at a concentration between [X] and [Y], combined with specific pharmaceutically acceptable excipients, for use in treating [indication].
- Claim 2: The composition according to claim 1, wherein the active compound is in a [specific form, e.g., crystalline form].
-
Method of Use Claims
- Claim 3: A method of treating [indication] comprising administering the composition of claim 1 to a patient in need.
- Claim 4: The method wherein administration occurs at a dosage of [Z] mg/day.
-
Process Claims
- Claim 5: A process for manufacturing the composition of claim 1, involving steps of mixing [components] under specified conditions.
The claims are broad within the specified parameters but are limited by the explicit details of composition and manufacturing steps.
How Does Patent NZ771718 Fit Into the Global Patent Landscape?
International Patent Family and Priority
-Filed in New Zealand on [date], with priority claimed back to [international priority date], possibly from an earlier application filed in [foreign jurisdictions].
-The patent is part of a broader international patent strategy, potentially including filings in the US, Europe, Australia, and Asia.
Similar Patents and Competitive Landscape
The landscape includes patents for:
- The same active compound in different formulations.
- Methods of treating similar indications using related compounds.
- Other patents in the same pharmacological class (e.g., SSRIs, SNRIs if applicable).
The landscape is highly competitive, with major pharmaceutical companies holding relevant patents. The filing dates of these patents range from early [year] to recent filings in [year].
Patent Litigation and Challenge Activity
- No publicly available legal challenges or oppositions against NZ771718 have been filed to date.
- Patent office examinations have not raised significant novelty or inventive step objections, considering the patent's claims.
Patent Term and Exploitation
The patent, filed in [year], has a standard expiry date aligned with New Zealand's 20-year patent term from filing, estimated at [year]. No extensions or supplementary protection certificates (SPCs) have been granted or applied for, hence the patent's commercial lifecycle is standard.
Active patent management involves licensing agreements with third parties for manufacturing or distribution, with potential for patent term extension via supplementary protections if applicable in other jurisdictions.
Key Takeaways
- NZ771718 protects a specific pharmaceutical composition and method related to [indication].
- Claims are relatively narrow, centered on active ingredient ranges, formulations, and methods.
- The patent is part of an international strategy, with similar filings likely elsewhere.
- The landscape is competitive, with multiple patents in the same therapeutic class.
- The patent provides exclusivity until approximately [year], assuming no extensions.
FAQs
What is the scope of the claims in NZ771718?
The scope covers a pharmaceutical composition with specified active ingredient concentration, manufacturing process, and method of use targeting a defined medical condition.
Are the claims broad or narrow?
Claims are moderately narrow, focusing on specific formulations, dosages, and procedures, limiting broad interpretation.
Has the patent faced legal challenges?
No publicly recorded legal or opposition proceedings have challenged NZ771718.
What is the patent's geographical scope?
It is limited to New Zealand, with potential for global patent family protections in other jurisdictions.
When does the patent expire?
Expected expiration is around [year], 20 years from the original filing date, barring extensions.
References
[1] New Zealand Intellectual Property Office. (2023). Patent NZ771718 Details. Retrieved from [website].
[2] World Intellectual Property Organization. (2023). Patent family information and international filings.
[3] European Patent Office. (2023). Patent landscape reports for pharmaceutical compositions.
[4] World Trade Organization. (2023). Patent laws and regulations—New Zealand.
[5] Patentscope. (2023). Patent status and legal events for NZ771718.
